Figure 3. Overall and relapse free survival analysis of the 51 breast cancer patients, uniformly treated in a prospective study, based upon different gene expression classification. A. Overall survival and B. Relapse-free survival for the five expression-based tumor subtypes based on the classification presented in Figure 1 (Luminal B and C were considered one group). C. Overall survival estimated for the six-subtype classification with three different Luminal Subtypes presented in Figure 1. D. Overall survival based on the five-subtype classification presented in Figure 2B and Supplementary Information, Figure 6.